PHARMACEUTICAL CARRIER FORMULATION
Kind Code:
A1
Abstract not available for EP1216029
Abstract of corresponding document: WO0122942
This invention provides carrier systems useful in preparing pharmaceutical formulations, the systems comprising, by weight percentage, from about 1 % to about 20 %, preferably from about 5 % to about 12 %, of a surfactant component; from about 55 % to about 93 %, preferably from about 60 % to about 85 %, of a component of one or more polyethylene glycols (PEG); and from about 1 % to about 25 %, preferably from about 5 % to about 15 %, of one or more sucrose fatty acid esters or polyvinylpyrrolidone (PVP) with a K value between about 15 and about 90, preferably with a K value of from about 16 to about 18, most preferably about 17, as defined in USP/NF, or a combination of one or more sucrose fatty acid esters or PVP, and, optionally, one or more pharmaceutically acceptable preservatives or antioxidants, such as BHA, BHT, ascorbyl palmitate or benzyl alcohol.

Inventors:
Yoon, Joseph Kyuwung (US)
Saunders, Richard William (US)
Fawzi, Mahdi Bakir (US)
Application Number:
EP20000966880
Publication Date:
06/26/2002
Filing Date:
09/26/2000
View Patent Images:
Export Citation:
Assignee:
AMERICAN CYANAMID CO (US)
International Classes:
A61K47/26; A61K47/26; A61K9/48; A61K9/48; A61K47/28; A61K47/28; A61K47/32; A61K47/32; A61K47/34; A61K47/34; (IPC1-7): A61K9/16; A61K9/48
European Classes:
A61K9/48H4; A61K9/48H6
Other References:
See references of WO 0122942A1




<- Previous Patent (BIODEGRADABLE EXCIPI...)   |   Next Patent (ANTI-INFLAMMATORY PH...) ->